Primary Central Nervous System Lymphoma: Molecular Pathogenesis and Advances in Treatment

被引：31

作者：

Cai, Qingqing ^{[1
]}

Fang, Yu ^{[1
]}

Young, Ken H. ^{[2
]}

机构：

[1] Sun Yat Sen Univ, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Dept Med Oncol,Canc Ctr, Guangzhou 510060, Guangdong, Peoples R China

[2] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, 1515 Holcombe Blvd, Houston, TX 77030 USA

来源：

TRANSLATIONAL ONCOLOGY | 2019年 / 12卷 / 03期

基金：

中国国家自然科学基金;

关键词：

PRIMARY CNS LYMPHOMA; HIGH-DOSE CHEMOTHERAPY; WHOLE-BRAIN RADIOTHERAPY; STEM-CELL TRANSPLANTATION; INTERNATIONAL EXTRANODAL LYMPHOMA; RECURRENT PRIMARY CNS; UNDER-THE-CURVE; SALVAGE THERAPY; INTENSIVE CHEMOTHERAPY; 1ST-LINE TREATMENT;

D O I：

10.1016/j.tranon.2018.11.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Primary central nervous system lymphoma (PCNSL) is a group of extranodal non-Hodgkin lymphoma that exhibits specific biological characteristics and clinical behavior, with an aggressive disease course and unsatisfactory patient outcomes. It is of great importance to identify aberrant genetic loci and important molecular pathways that might suggest potential targets for new therapeutics and provide prognostic information. In this review, we listed various genetic and epigenetic alterations that are involved in PCNSL pathogenesis. In the aspect of treatment, we summarized the related literatures and evaluated the efficacy of surgery, induction chemotherapy, radiotherapy, intrathecal chemotherapy, and autologous stem cell transplantation in PCNSL. We also proposed the possible new agents for recurrent and relapse PCNSL based on the result of recent clinical researches.

引用

页码：523 / 538

页数：16

共 139 条

[1] Primary central nervous system lymphoma: The Memorial Sloan-Kettering Cancer Center prognostic model [J].

Abrey, Lauren E. ;

Ben-Porat, Leah ;

Panageas, Katherine S. ;

Yahalom, Joachim ;

Berkey, Brian ;

Curran, Walter ;

Schultz, Christopher ;

Leibel, Steven ;

Nelson, Diana ;

Mehta, Minesh ;

DeAngelis, Lisa M. .

JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (36) :5711-5715

[2] Intensive methotrexate and cytarabine followed by high-dose chemotherapy with autologous stem-cell rescue in patients with newly diagnosed primary CNS lymphoma: An intent-to-treat analysis [J].

Abrey, LE ;

Moskowitz, CH ;

Mason, WP ;

Crump, M ;

Stewart, D ;

Forsyth, P ;

Paleologos, N ;

Correa, DD ;

Anderson, ND ;

Caron, D ;

Zelenetz, A ;

Nimer, SD ;

DeAngelis, LM .

JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) :4151-4156

[3] Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma [J].

Abrey, LE ;

Batchelor, TT ;

Ferreri, AJM ;

Gospodarowicz, M ;

Pulczynski, EJ ;

Zucca, E ;

Smith, JR ;

Korfel, A ;

Soussain, C ;

DeAngelis, LM ;

Neuwelt, EA ;

O'Neill, BP ;

Thiel, E ;

Shenkier, T ;

Graus, F ;

van den Bent, M ;

Seymour, JF ;

Poortmans, P ;

Armitage, JO ;

Cavalli, F .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (22) :5034-5043

[4] O6-methylguanine-DNA methyltransferase promoter methylation in 45 primary central nervous system lymphomas: quantitative assessment of methylation and response to temozolomide treatment [J].

Adachi, Jun-ichi ;

Mishima, Kazuhiko ;

Wakiya, Kenji ;

Suzuki, Tomonari ;

Fukuoka, Kohei ;

Yanagisawa, Takaaki ;

Matsutani, Masao ;

Sasaki, Atsushi ;

Nishikawa, Ryo .

JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (01) :147-153

[5]

Ambady Prakash, 2015, CNS Oncol, V4, P393, DOI 10.2217/cns.15.34

[6] Blood-Brain Barrier Disruption and Intra-Arterial Methotrexate-Based Therapy for Newly Diagnosed Primary CNS Lymphoma: A Multi-Institutional Experience [J].

Angelov, Lilyana ;

Doolittle, Nancy D. ;

Kraemer, Dale F. ;

Siegal, Tali ;

Barnett, Gene H. ;

Peereboom, David M. ;

Stevens, Glen ;

McGregor, John ;

Jahnke, Kristoph ;

Lacy, Cynthia A. ;

Hedrick, Nancy A. ;

Shalom, Edna ;

Ference, Sandra ;

Bell, Susan ;

Sorenson, Lisa ;

Tyson, Rose Marie ;

Haluska, Marianne ;

Neuwelt, Edward A. .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (21) :3503-3509

[7]

[Anonymous], 2008, WHO Classification of Tumors of Haematopoietic and Lymphoid Tissues

[8] Salvage treatment with etoposide (VP-16), ifosfamide and cytarabine (Ara-C) for patients with recurrent primary central nervous system lymphoma [J].

Arellano-Rodrigo, E ;

López-Guillermo, A ;

Bessell, EM ;

Nomdedeu, B ;

Montserrat, E ;

Graus, F .

EUROPEAN JOURNAL OF HAEMATOLOGY, 2003, 70 (04) :219-224

[9] Gene Mutation Profiles in Primary Diffuse Large B Cell Lymphoma of Central Nervous System: Next Generation Sequencing Analyses [J].

Balint, Milena Todorovic ;

Jelicic, Jelena ;

Mihaljevic, Biljana ;

Kostic, Jelena ;

Stanic, Bojana ;

Balint, Bela ;

Pejanovic, Nadja ;

Lucic, Bojana ;

Tosic, Natasa ;

Marjanovic, Irena ;

Stojiljkovic, Maja ;

Karan-Djurasevic, Teodora ;

Perisic, Ognjen ;

Rakocevic, Goran ;

Popovic, Milos ;

Raicevic, Sava ;

Bila, Jelena ;

Antic, Darko ;

Andjelic, Bosko ;

Pavlovic, Sonja .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2016, 17 (05)

[10] Identification of microRNAs in the cerebrospinal fluid as marker for primary diffuse large B-cell lymphoma of the central nervous system [J].

Baraniskin, Alexander ;

Kuhnhenn, Jan ;

Schlegel, Uwe ;

Chan, Andrew ;

Deckert, Martina ;

Gold, Ralf ;

Maghnouj, Abdelouahid ;

Zoellner, Hannah ;

Reinacher-Schick, Anke ;

Schmiegel, Wolff ;

Hahn, Stephan A. ;

Schroers, Roland .

BLOOD, 2011, 117 (11) :3140-3146

← 1 2 3 4 5 6 7 8 9 10 →